Partners

Founded by brigham and women's hospital and massachusetts general hospital

Office of Continuing Professional Development

Topics in Hematologic Malignancies: On Demand

ASH 2014 Highlights.jpg



Five 30-minute on-demand archived presentations

Description

The care of patients with hematologic malignancies is evolving rapidly. This continuing medical education activity will discuss new developments in the diagnosis and treatment of hematologic malignancies, as presented at the 2015 Annual Meeting of the American Society of Hematology (ASH).

During these five, half-hour online presentations, specialists in the field will share the latest updates in lymphoma, leukemia, and stem cell transplantation. Through case-based presentations and Q&A, viewers will gain a deeper understanding of emerging treatments available for blood cancers and blood disorders and learn how these new therapies can be integrated into daily practice.

Learning Objectives

At the conclusion of the course, the learners will be able to:

1. Provide an overview and highlight the recent medical advances presented at the 2015 Annual Meeting of the American Society of Hematology (ASH), which will help physicians achieve better patient outcomes.
2. Recognize appropriate management and treatment options for hematologic malignancies, specifically lymphoma, leukemia, and stem cell transplantation, and utilize these approaches in routine clinical practice.

Target Audience

This course is designed for hematologists, medical oncologists, internists, nurse practitioners, oncology nurses, and other interested healthcare providers.

Agenda

To complete each of the five sessions, you must view the half-hour presentation and complete the pre-test, post-test and evaluation.

Release Date:
October 5, 2016
Expiration Date: October 4, 2017

On-Demand Event Details: Each half-hour presentation is available on-demand for one year.

Modules:

Actue Myeloid Leukemia (AML), Acute Promyelocytic Leukemia (APL), and Myelodysplastic Syndrome (MDS)
Richard M. Stone, MD

Lymphoma
Ann S. LaCasce, MD

Chronic Lymphocytic Leukemia (CLL)
Matthew S. Davids, MD

Stem Cell Transplantation
Corey S. Cutler, MD, MPH, FRCPC

Acute Lymphocytic Leukemia (ALL) and Chronic Myelogenous Leukemia (CML)
Daniel J. DeAngelo, MD, PhD

Faculty

Corey S. Cutler, MD, MPH, FRCPC
Medical Oncologist, Adult Stem Cell Transplantation Program,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine,
Harvard Medical School

Matthew S. Davids, MD
Medical Oncologist, Chronic Lymphocytic Leukemia Center,
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Medicine,
Harvard Medical School

Daniel J. DeAngelo, MD, PhD
Director, Clinical and Translational Research,
Adult Leukemia Program,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine,
Harvard Medical School

Ann S. LaCasce, MD
Director, Dana-Farber/Partners CancerCare Hematology-Medical Oncology Fellowship Program,
Medical Oncologist, Adult Lymphoma Program,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine,
Harvard Medical School

Richard M. Stone, MD
Director, Adult Leukemia Program,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine,
Harvard Medical School

Registration Fees

$50 for access to all presentations

Fees are non-refundable.

Contact

For questions, contact Partners Office of Continuing Professional Development at partnerscpd@partners.orgor 617-726-7465.

Provided by:

Dana-Farber/Brigham and Women's Cancer Center and Partners HealthCare

ASH 2014 Highlights.jpg


Partners_FoundedBy.jpg

CME Information

Release Date:October 5, 2016
Expiration Date:
October 4, 2017

Activity Title: Stem Cell Transplantation

Accreditation
Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this enduring material for a maximum of 0.5AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Title: Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia (APL), and Myelodysplastic Syndrome (MDS)

Accreditation
Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this enduring material for a maximum of 1AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Title: Lymphoma

Accreditation
Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this enduring material for a maximum of 1AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Title: Chronic Lymphocytic Leukemia (CLL)

Accreditation
Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this enduring material for a maximum of 1AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Title: Acute Lymphocytic Leukemia (ALL) and Chronic Myelogenous Leukemia (CML)

Accreditation
Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this enduring material for a maximum of 0.75AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



This internet-based CME activity is best experienced Microsoft Internet Explorer 9.0 or later, Mozilla Firefox 13 or later, Chrome 16 or later, Safari (version 5 or later)

Hardware/Software Specifications:
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, and Microsoft PowerPoint.

Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 13+, Internet Explorer 9.0+, Safari 13+, or Google Chrome 16+
Operating System: Windows Vista,7,8 or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements:
Windows PC:
Intel Pentium 4 or equivalent with 2.33 GHz processor; Windows XP; 512 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 3+, Internet Explorer 7.0+, Safari 4+, Google Chrome, or Opera
Macintosh:
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 128MB of video memory; Sound Card: at least 16-bit